■ 영문 제목 : Global Extracorporeal Membrane Oxygenation Machines Market 2023-2027
|
 | ■ 상품코드 : IRTNTR40185-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2022년 12월 ■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (24시간 이내)
■ 조사대상 지역 : 북미, 유럽, 아시아, 기타 지역
■ 산업 분야 : 의료 기기
|
■ 판매가격 / 옵션
(부가세 10% 별도)
Single User (1명 열람용) | USD2,500 ⇒환산₩3,375,000 | 견적의뢰/주문/질문 |
Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산₩5,400,000 | 견적의뢰/주문/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
Technavio사는 세계의 에크모 (ECMO) 시장 규모가 2022년부터 2027년까지 연평균 10.05% 성장하여, 243.6백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 보고서는 세계의 에크모 (ECMO) 시장을 조사 대상으로 하여, 개요, 시장 현황, 시장 규모 예측, 과거 시장 규모, 파이브 포스 분석, 모달리티별 (정맥류, 동맥-정맥, 정맥 동맥) 분석, 제품별 (ECMO 장치, 소프트웨어) 분석, 고객 현황, 지역별 현황 (북미, 유럽, 아시아 태평양, 기타 지역, 미국, 독일, 캐나다, 영국, 중국) 분석, 추진 요인/과제/동향, 기업 현황, 기업 분석 등의 항목을 게재하고 있습니다. 덧붙여 본 조사 자료는 Abbott Laboratories, Abiomed Inc., Braile Biomedica, Chalice Medical Ltd., CytoSorbents Europe GmbH, Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, MC3 Cardiopulmonar Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Palex Medical SA, Sechrist Industries Inc., Senko Medical Industry Co. Ltd., Spectrum Medical Ltd., Terumo Corp., Xenios AG 등의 기업 정보를 포함하고 있습니다.
・개요
・시장 현황
・시장 규모 예측
・과거 시장 규모
・파이브 포스 분석
・세계의 에크모 (ECMO) 시장 규모 : 모달리티별
- 정맥류 에크모의 시장 규모
- 동맥 - 정맥 에크모의 시장 규모
- 정맥동맥 에크모의 시장 규모
・세계의 에크모 (ECMO) 시장 규모 : 제품별
- ECMO 장치의 시장 규모
- 소프트웨어의 시장 규모
・고객 현황
・세계의 에크모 (ECMO) 시장 규모 : 지역별
- 북미의 에크모 (ECMO) 시장 규모
- 유럽의 에크모 (ECMO) 시장 규모
- 아시아 태평양의 의 에크모 (ECMO) 시장 규모
- 기타 지역의 에크모 (ECMO) 시장 규모
- 미국의 에크모 (ECMO) 시장 규모
- 독일의 에크모 (ECMO) 시장 규모
- 캐나다의 에크모 (ECMO) 시장 규모
- 영국의 에크모 (ECMO) 시장 규모
- 중국의 에크모 (ECMO) 시장 규모
・추진 요인/과제/동향
・기업 현황
・기업 분석
Technavio 사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 Technavio 사의 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
■ 보고서 개요Technavio Announces the Publication of its Research Report – Global Extracorporeal Membrane Oxygenation Machines Market 2023-2027Technavio recognizes the following companies as the key players in the global extracorporeal membrane oxygenation machines market: Abbott Laboratories, Abiomed Inc., Braile Biomedica, Chalice Medical Ltd., CytoSorbents Europe GmbH, Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Palex Medical SA, Sechrist Industries Inc., Senko Medical Industry Co. Ltd., Spectrum Medical Ltd., Terumo Corp., and Xenios AG.
Commenting on the report, an analyst from Technavio said: “The latest trend gaining momentum in the market is technological advances.”
According to the report, one of the major drivers for this market is the increasing incidence of respiratory and heart failure.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit- www.technavio.com/report/extracorporeal-membrane-oxygenation-machine-market-industry-analysis
Technavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit- www.technavio.com/industries/health-care-equipment
Follow us on Twitter @Technavio
■ 보고서 목차• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Modality
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global extracorporeal membrane oxygenation machines market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global extracorporeal membrane oxygenation machines market 2017 – 2021 ($ million)
o 4.2 Modality Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Modality Segment 2017 – 2021 ($ million)
o 4.3 Product Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Modality
o 6.1 Market segments
o Exhibit 30: Chart on Modality – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Modality – Market share 2022-2027 (%)
o 6.2 Comparison by Modality
o Exhibit 32: Chart on Comparison by Modality
o Exhibit 33: Data Table on Comparison by Modality
o 6.3 Veno-venous and arterio-venous – Market size and forecast 2022-2027
o Exhibit 34: Chart on Veno-venous and arterio-venous – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Veno-venous and arterio-venous – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Veno-venous and arterio-venous – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Veno-venous and arterio-venous – Year-over-year growth 2022-2027 (%)
o 6.4 Veno-arterial – Market size and forecast 2022-2027
o Exhibit 38: Chart on Veno-arterial – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Veno-arterial – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Veno-arterial – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Veno-arterial – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Modality
o Exhibit 42: Market opportunity by Modality ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 43: Chart on Product – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Product – Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 45: Chart on Comparison by Product
o Exhibit 46: Data Table on Comparison by Product
o 7.3 ECMO machines – Market size and forecast 2022-2027
o Exhibit 47: Chart on ECMO machines – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on ECMO machines – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on ECMO machines – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on ECMO machines – Year-over-year growth 2022-2027 (%)
o 7.4 Softwares – Market size and forecast 2022-2027
o Exhibit 51: Chart on Softwares – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Softwares – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Softwares – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Softwares – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product
o Exhibit 55: Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 59: Chart on Geographic comparison
o Exhibit 60: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 61: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 63: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 65: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 77: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 81: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 Canada – Market size and forecast 2022-2027
o Exhibit 85: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.10 UK – Market size and forecast 2022-2027
o Exhibit 89: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 93: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 97: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 98: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 100: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 101: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 102: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 103: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 104: Abbott Laboratories – Overview
o Exhibit 105: Abbott Laboratories – Business segments
o Exhibit 106: Abbott Laboratories – Key news
o Exhibit 107: Abbott Laboratories – Key offerings
o Exhibit 108: Abbott Laboratories – Segment focus
o 12.4 Braile Biomedica
o Exhibit 109: Braile Biomedica – Overview
o Exhibit 110: Braile Biomedica – Product / Service
o Exhibit 111: Braile Biomedica – Key offerings
o 12.5 Chalice Medical Ltd.
o Exhibit 112: Chalice Medical Ltd. – Overview
o Exhibit 113: Chalice Medical Ltd. – Product / Service
o Exhibit 114: Chalice Medical Ltd. – Key offerings
o 12.6 Eurosets Srl
o Exhibit 115: Eurosets Srl – Overview
o Exhibit 116: Eurosets Srl – Product / Service
o Exhibit 117: Eurosets Srl – Key offerings
o 12.7 Fresenius Medical Care AG and Co. KGaA
o Exhibit 118: Fresenius Medical Care AG and Co. KGaA – Overview
o Exhibit 119: Fresenius Medical Care AG and Co. KGaA – Business segments
o Exhibit 120: Fresenius Medical Care AG and Co. KGaA – Key news
o Exhibit 121: Fresenius Medical Care AG and Co. KGaA – Key offerings
o Exhibit 122: Fresenius Medical Care AG and Co. KGaA – Segment focus
o 12.8 Getinge AB
o Exhibit 123: Getinge AB – Overview
o Exhibit 124: Getinge AB – Business segments
o Exhibit 125: Getinge AB – Key news
o Exhibit 126: Getinge AB – Key offerings
o Exhibit 127: Getinge AB – Segment focus
o 12.9 LivaNova Plc
o Exhibit 128: LivaNova Plc – Overview
o Exhibit 129: LivaNova Plc – Business segments
o Exhibit 130: LivaNova Plc – Key offerings
o Exhibit 131: LivaNova Plc – Segment focus
o 12.10 MC3 Cardiopulmonary
o Exhibit 132: MC3 Cardiopulmonary – Overview
o Exhibit 133: MC3 Cardiopulmonary – Product / Service
o Exhibit 134: MC3 Cardiopulmonary – Key offerings
o 12.11 Medtronic Plc
o Exhibit 135: Medtronic Plc – Overview
o Exhibit 136: Medtronic Plc – Business segments
o Exhibit 137: Medtronic Plc – Key news
o Exhibit 138: Medtronic Plc – Key offerings
o Exhibit 139: Medtronic Plc – Segment focus
o 12.12 MicroPort Scientific Corp.
o Exhibit 140: MicroPort Scientific Corp. – Overview
o Exhibit 141: MicroPort Scientific Corp. – Business segments
o Exhibit 142: MicroPort Scientific Corp. – Key offerings
o Exhibit 143: MicroPort Scientific Corp. – Segment focus
o 12.13 Nipro Corp.
o Exhibit 144: Nipro Corp. – Overview
o Exhibit 145: Nipro Corp. – Business segments
o Exhibit 146: Nipro Corp. – Key offerings
o Exhibit 147: Nipro Corp. – Segment focus
o 12.14 OriGen Biomedical Inc.
o Exhibit 148: OriGen Biomedical Inc. – Overview
o Exhibit 149: OriGen Biomedical Inc. – Product / Service
o Exhibit 150: OriGen Biomedical Inc. – Key offerings
o 12.15 Sechrist Industries Inc.
o Exhibit 151: Sechrist Industries Inc. – Overview
o Exhibit 152: Sechrist Industries Inc. – Product / Service
o Exhibit 153: Sechrist Industries Inc. – Key offerings
o 12.16 Terumo Corp.
o Exhibit 154: Terumo Corp. – Overview
o Exhibit 155: Terumo Corp. – Business segments
o Exhibit 156: Terumo Corp. – Key news
o Exhibit 157: Terumo Corp. – Key offerings
o Exhibit 158: Terumo Corp. – Segment focus
o 12.17 Xenios AG
o Exhibit 159: Xenios AG – Overview
o Exhibit 160: Xenios AG – Product / Service
o Exhibit 161: Xenios AG – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 162: Inclusions checklist
o Exhibit 163: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 164: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 165: Research methodology
o Exhibit 166: Validation techniques employed for market sizing
o Exhibit 167: Information sources
o 13.5 List of abbreviations
o Exhibit 168: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Modality
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global extracorporeal membrane oxygenation machines market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Modality Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Modality – Market share 2022-2027 (%)
Exhibits31: Data Table on Modality – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Modality
Exhibits33: Data Table on Comparison by Modality
Exhibits34: Chart on Veno-venous and arterio-venous – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Veno-venous and arterio-venous – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Veno-venous and arterio-venous – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Veno-venous and arterio-venous – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Veno-arterial – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Veno-arterial – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Veno-arterial – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Veno-arterial – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Modality ($ million)
Exhibits43: Chart on Product – Market share 2022-2027 (%)
Exhibits44: Data Table on Product – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Product
Exhibits46: Data Table on Comparison by Product
Exhibits47: Chart on ECMO machines – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on ECMO machines – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on ECMO machines – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on ECMO machines – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Softwares – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Softwares – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Softwares – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Softwares – Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Product ($ million)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits97: Market opportunity By Geographical Landscape ($ million)
Exhibits98: Impact of drivers and challenges in 2022 and 2027
Exhibits99: Overview on Criticality of inputs and Factors of differentiation
Exhibits100: Overview on factors of disruption
Exhibits101: Impact of key risks on business
Exhibits102: Vendors covered
Exhibits103: Matrix on vendor position and classification
Exhibits104: Abbott Laboratories – Overview
Exhibits105: Abbott Laboratories – Business segments
Exhibits106: Abbott Laboratories – Key news
Exhibits107: Abbott Laboratories – Key offerings
Exhibits108: Abbott Laboratories – Segment focus
Exhibits109: Braile Biomedica – Overview
Exhibits110: Braile Biomedica – Product / Service
Exhibits111: Braile Biomedica – Key offerings
Exhibits112: Chalice Medical Ltd. – Overview
Exhibits113: Chalice Medical Ltd. – Product / Service
Exhibits114: Chalice Medical Ltd. – Key offerings
Exhibits115: Eurosets Srl – Overview
Exhibits116: Eurosets Srl – Product / Service
Exhibits117: Eurosets Srl – Key offerings
Exhibits118: Fresenius Medical Care AG and Co. KGaA – Overview
Exhibits119: Fresenius Medical Care AG and Co. KGaA – Business segments
Exhibits120: Fresenius Medical Care AG and Co. KGaA – Key news
Exhibits121: Fresenius Medical Care AG and Co. KGaA – Key offerings
Exhibits122: Fresenius Medical Care AG and Co. KGaA – Segment focus
Exhibits123: Getinge AB – Overview
Exhibits124: Getinge AB – Business segments
Exhibits125: Getinge AB – Key news
Exhibits126: Getinge AB – Key offerings
Exhibits127: Getinge AB – Segment focus
Exhibits128: LivaNova Plc – Overview
Exhibits129: LivaNova Plc – Business segments
Exhibits130: LivaNova Plc – Key offerings
Exhibits131: LivaNova Plc – Segment focus
Exhibits132: MC3 Cardiopulmonary – Overview
Exhibits133: MC3 Cardiopulmonary – Product / Service
Exhibits134: MC3 Cardiopulmonary – Key offerings
Exhibits135: Medtronic Plc – Overview
Exhibits136: Medtronic Plc – Business segments
Exhibits137: Medtronic Plc – Key news
Exhibits138: Medtronic Plc – Key offerings
Exhibits139: Medtronic Plc – Segment focus
Exhibits140: MicroPort Scientific Corp. – Overview
Exhibits141: MicroPort Scientific Corp. – Business segments
Exhibits142: MicroPort Scientific Corp. – Key offerings
Exhibits143: MicroPort Scientific Corp. – Segment focus
Exhibits144: Nipro Corp. – Overview
Exhibits145: Nipro Corp. – Business segments
Exhibits146: Nipro Corp. – Key offerings
Exhibits147: Nipro Corp. – Segment focus
Exhibits148: OriGen Biomedical Inc. – Overview
Exhibits149: OriGen Biomedical Inc. – Product / Service
Exhibits150: OriGen Biomedical Inc. – Key offerings
Exhibits151: Sechrist Industries Inc. – Overview
Exhibits152: Sechrist Industries Inc. – Product / Service
Exhibits153: Sechrist Industries Inc. – Key offerings
Exhibits154: Terumo Corp. – Overview
Exhibits155: Terumo Corp. – Business segments
Exhibits156: Terumo Corp. – Key news
Exhibits157: Terumo Corp. – Key offerings
Exhibits158: Terumo Corp. – Segment focus
Exhibits159: Xenios AG – Overview
Exhibits160: Xenios AG – Product / Service
Exhibits161: Xenios AG – Key offerings
Exhibits162: Inclusions checklist
Exhibits163: Exclusions checklist
Exhibits164: Currency conversion rates for US$
Exhibits165: Research methodology
Exhibits166: Validation techniques employed for market sizing
Exhibits167: Information sources
Exhibits168: List of abbreviations
|

※본 조사보고서 [세계의 에크모 (ECMO) 시장 (2023~2027) : 정맥류, 동맥-정맥, 정맥 동맥] (코드 : IRTNTR40185-23) 판매에 관한 면책사항을 반드시 확인하세요. |
※본 조사보고서 [세계의 에크모 (ECMO) 시장 (2023~2027) : 정맥류, 동맥-정맥, 정맥 동맥] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!